Arch Biopartners Inc

NEW
OTCPK:ACHFF (Canada)  
$ 0.64 +0.032 (+5.3%) 10:08 PM EST
At Loss
Market Cap:
$ 45.44M
Enterprise V:
$ 46.94M
Volume:
22.00K
Avg Vol (2M):
27.41K
Trade In:
Volume:
22.00K
At Loss
Avg Vol (2M):
27.41K

Business Description

Description
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
Name Current Vs Industry Vs History
Cash-To-Debt
0.17
Equity-to-Asset
-7.87
Debt-to-Equity
-0.7
Debt-to-EBITDA
-1.1
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
-3.6
3-Year Book Growth Rate
6.4
Name Current Vs Industry Vs History
5-Day RSI
66.31
9-Day RSI
70
14-Day RSI
70.13
3-1 Month Momentum %
-18.38
6-1 Month Momentum %
-64.88
12-1 Month Momentum %
-77.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.11
Quick Ratio
0.11
Cash Ratio
0.11

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-2
Shareholder Yield %
-2.2
Name Current Vs Industry Vs History
ROA %
-919.8
ROIC %
-95.62
3-Year ROIIC %
-41.01
Moat Score
2
Tariff Resilience Score
6

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-27.26
EV-to-EBITDA
-27.26
EV-to-Forward-Revenue
51
EV-to-FCF
-57.91
Earnings Yield (Greenblatt) %
-3.67
FCF Yield %
-1.78

GF Valueâ„¢

Arch Biopartners Inc Filings

Filing Date Document Date Form
No Filing Data

Arch Biopartners Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Guru Commentaries on OTCPK:ACHFF

No articles.

Press Release

Subject Date
No Press Release

Articles on Arch Biopartners Inc

No articles.